SCHEMBL1495210

SCHEMBL1495210

COC(=O)c1c(C)ccc(OCc2ccccc2)c1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 3/20 0.49
MAPT P10636 3/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
LMNA P02545 2/20 0.47
RAB9A P51151 2/20 0.47
FFAR4 Q5NUL3 1/20 0.47
PTPN1 P18031 1/20 0.47
HPGD P15428 2/20 0.47
SMPD1 P17405 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
NPC1 O15118 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
RXRA P19793 1/20 0.45
RXRB P28702 1/20 0.45
RXRG P48443 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1495302 0.87 MRGPRX4 (0.55) MRGPRX4MAPTL3MBTL1FFAR4PTPN1
SCHEMBL1495284 0.85 EGFR (0.51) MRGPRX4LMNARAB9AHPGDSMPD1
SCHEMBL9724299 0.82 HPGD (0.56) MAPTL3MBTL1LMNARAB9AFFAR4
SCHEMBL18080982 0.81 LMNA (0.54) MRGPRX4MAPTL3MBTL1LMNARAB9A
SCHEMBL29179289 0.81 MRGPRX4 (0.51) MRGPRX4LMNARAB9AHPGDSMPD1
SCHEMBL18133317 0.78 MAPT (0.55) MRGPRX4MAPTL3MBTL1FFAR4PTPN1
SCHEMBL1495316 0.78 CA12 (0.41) MAPTLMNARAB9AHPGDSMN1; SMN2
SCHEMBL24983636 0.77 LMNA (0.58) MRGPRX4MAPTLMNARAB9AHPGD
SCHEMBL31644614 0.77 LMNA (0.58) MRGPRX4MAPTLMNARAB9AHPGD
SCHEMBL21884498 0.77 XDH (0.48) MRGPRX4LMNAFFAR4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2470532-A1 1H-PYRAZOLO [ 3, 4-B]PYRIDINE COMPOUNDS FOR INHIBITING RAF KINASE Array Biopharma, Inc. (US) 2012-07-04 EP disclosed
US-20120157452-A1 1H-PYRAZOLO[3,4-B] PYRIDINE COMPOUNDS FOR INHIBITING RAF KINASE GENENTECH, INC. (US) 2012-06-21 US disclosed
WO-2011025968-A1 1H-PYRAZOLO [ 3, 4-B] PYRIDINE COMPOUNDS FOR INHIBITING RAF KINASE ARRAY BIOPHARMA INC. (US) 2011-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157452-A1 1H-PYRAZOLO[3,4-B] PYRIDINE COMPOUNDS FOR INHIBITING RAF KINASE BRAF, RAF1, ARAF MRGPRX4 2311/4885MAPT 1045/4885L3MBTL1 2162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.